open access

Vol 1, No 3 (2016)
CASE REPORTS
Published online: 2016-11-04
Get Citation

Early treatment of subretinal haemorrhage in the course of exudative AMD using SF6 gas infusion and injection of intravitreal anti-VEGF — case report

Anna Heinke Knudsen, Katarzyna Michalska-Małecka, Rafał Leszczyński
DOI: 10.5603/OJ.2016.0019
·
Ophthalmol J 2016;1(3):99-102.

open access

Vol 1, No 3 (2016)
CASE REPORTS
Published online: 2016-11-04

Abstract

Submacular haemorrhages, which are mostly caused by exudative age-related macular degeneration, lead to a significant deterioration of visual acuity and have a poor prognosis. Therefore, quick implementation of treatment is essential. The aim was to report a case of 68-year-old patient suffering from extensive haemorrhage covering the macula treated with pure sulphur hexafluoride (SF6) gas infusion and two anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections. A patient was referred to the clinic due to a sudden deterioration of vision and the appearance of a black spot in central vision in the right eye. The patient underwent the infusion of 0.5 ml of pure SF6 followed by maintenance of face-down position postoperatively resulting in partial displacement of submacular haemorrhage. One month after the surgery the patient was referred to two intravitreal injections of anti-VEGF in monthly intervals. The effectiveness of the treatment is confirmed by OCT examination and visual acuity results (from CF 1’ before treatment to 5/12 after the treatment). A combination of SF6 gas infusion and anti-VEGF intravitreal injections turned out to be an effective and safe method of submacular haemorrhage treatment. Early diagnosis and treatment implementation resulted in significant improvement of visual acuity.

Abstract

Submacular haemorrhages, which are mostly caused by exudative age-related macular degeneration, lead to a significant deterioration of visual acuity and have a poor prognosis. Therefore, quick implementation of treatment is essential. The aim was to report a case of 68-year-old patient suffering from extensive haemorrhage covering the macula treated with pure sulphur hexafluoride (SF6) gas infusion and two anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections. A patient was referred to the clinic due to a sudden deterioration of vision and the appearance of a black spot in central vision in the right eye. The patient underwent the infusion of 0.5 ml of pure SF6 followed by maintenance of face-down position postoperatively resulting in partial displacement of submacular haemorrhage. One month after the surgery the patient was referred to two intravitreal injections of anti-VEGF in monthly intervals. The effectiveness of the treatment is confirmed by OCT examination and visual acuity results (from CF 1’ before treatment to 5/12 after the treatment). A combination of SF6 gas infusion and anti-VEGF intravitreal injections turned out to be an effective and safe method of submacular haemorrhage treatment. Early diagnosis and treatment implementation resulted in significant improvement of visual acuity.

Get Citation

Keywords

age-related macular degeneration, anti-VEGF, haemorrhage, macula, SF6 gas

About this article
Title

Early treatment of subretinal haemorrhage in the course of exudative AMD using SF6 gas infusion and injection of intravitreal anti-VEGF — case report

Journal

Ophthalmology Journal

Issue

Vol 1, No 3 (2016)

Pages

99-102

Published online

2016-11-04

DOI

10.5603/OJ.2016.0019

Bibliographic record

Ophthalmol J 2016;1(3):99-102.

Keywords

age-related macular degeneration
anti-VEGF
haemorrhage
macula
SF6 gas

Authors

Anna Heinke Knudsen
Katarzyna Michalska-Małecka
Rafał Leszczyński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl